Brief: Vericel Q3 Net Income USD -3.7 Million
08/11/2023 12:55
Nov 08 (Reuters) - Vericel Q3 adjusted EBITDA USD 5.4 million. * Q3 gross margin 67% * outlook FY revenue USD 192.5-197.5 million
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook